BRIEF-Biogen completes submission of new drug application
September 26, 2016 at 07:45 AM EDT
* Biogen completes rolling submission of new drug application to FDA for nusinersen as a treatment for spinal muscular atrophy
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|